货号:A707632 同义名: MK0476 free base;MK-476
Montelukast是一种半胱氨酸白三烯受体1(CysLT1) 拮抗剂,广泛用于哮喘和过敏性疾病的预防与治疗,具有重要的临床应用。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | LTR ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Montelukast Sodium | ✔ | 98% | |||||||||||||||||
MK571 | ✔ | 98% | |||||||||||||||||
Zafirlukast | ✔ | 99% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Montelukast (MK0476 free base) is a potent, selective, and orally active antagonist of the cysteinyl leukotriene receptor 1 (CysLT1). It finds utility in asthma and liver injury research. Moreover, Montelukast exhibits antioxidant properties in intestinal ischemia-reperfusion injury, potentially mitigating cardiac damage. Additionally, it reduces eosinophil infiltration in asthmatic airways and holds promise for COVID-19 research[1][2][3][4]. |
体内研究 | Montelukast (3 mg/kg; oral gavage) confers protection against APAP-induced hepatotoxicity in mice[1]. Montelukast (1 mg/kg; miniosmotic pump administration) attenuates the airway remodeling alterations observed in OVA-treated mice and inhibits the effects mediated by cysteinyl leukotrienes (LTC4, LTD4, and LTE4) through the CysLT1 receptor[2]. Montelukast (1 mg/kg; miniosmotic pump administration) decreases the increased levels of IL-4 and IL-13 detected in the BAL fluid of OVA-treated mice[2]. |
体外研究 | Montelukast (5 μM; 1 h) attenuates APAP (Acetaminophen)-induced cell damage[1]. Montelukast (0.01-10 μM; 30 min) attenuates 5-oxo-ETE–induced cell migration and modulates the activation of the plasmin-plasminogen system[3]. Montelukast (10 μM; 18 h) regulates the activation of MMP-9[3]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.71mL 0.34mL 0.17mL |
8.53mL 1.71mL 0.85mL |
17.06mL 3.41mL 1.71mL |
CAS号 | 158966-92-8 |
分子式 | C35H36ClNO3S |
分子量 | 586.183 |
别名 | MK0476 free base;MK-476;MK0476 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,2-8°C |
溶解度 |
DMSO: 250 mg/mL(426.49 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |